Our Mission

To revolutionise the treatment of cerebrovascular and neurodegenerative diseases where there is no effective drug therapy available today. 

Diseases of cerebrovascular origins such as resistant hypertension, stroke, Alzheimer’s disease and vascular dementia rank alongside cancer as one of the greatest healthcare challenges faced by humanity, affecting one in three in later life.

Currently, there are no efficient drugs or treatment proven to modify the course of these diseases. Bioinduction will develop a precisely targetted brain pacemaker that offers new hope for the millions of sufferers.

As Wired Health reports: “the future of medication isn’t drugs and their countless side effects but electrical implants!”

1

billion

people across the
world have hypertension

140

million

are not managed
by drugs

7.5

million

die annually worldwide from heart disease and stroke caused by high blood pressure

The Solution

New brain targets identified

Cerebrovascular diseases have one thing in common: a reduction in the cerebral blood flow.

Bioinduction has developed and patented a new treatment that restores normal blood flow to the brain.

Skull-mounted brain pacemaker

To give millions of people access to this treatment, we have developed Picostim, a miniaturised brain pacemaker, which is small enough to be skull-mounted.

Picostim is a third of the size of current devices and can be implanted in half the time.

potential to improve live of millions of people

Team

We have a strong and experienced team to deliver our mission. We all have experience in medical device design and clinical investigations and are continually building our expert team to accelerate our product development and continue to develop the clinical evidence.

Ivor Gillbe

Chairman & Founder

Founded and successfully exited two companies:
Optimised Control Ltd and Motionbase Plc.

Nik Patel

Clinical Director

Senior neurosurgical consultant, key opinion leader in DBS and other neuromodulation therapies.

Helene Viatge

CEO

10 years’ experience in Medical devices sales and product launches

Jon Ottaway

Technical Director

15 years’ experience in medical devices software and hardware development.

John Spensley

Manufacturing Director

20 years’ experience in manufacturing of implantable medical devices and quality control.

Anton Jenkins

Non-exec Director

Chief Operating Officer Clinigen Group and key advisor to the Bioinduction board.
Work with us

Get in touch today to discuss our current career opportunities:

Contact

Timeline

2019

Parkinson’s human trial of Picostim

We are expecting to launch our first in-man clinical investigation of Picostim for late-stage Parkinson’s patients.

2018

Pilot study on Hypertension

Formalisation of long running research work on hypertension DBS targets. The first approved pilot study is launched with a small cohort of patients and gave highly encouraging results.

2016

OEM Partnership with Big pharma

Purchase of 38 pre-CE Picostim System by a major pharmaceutical company for research use. This generated over £450k in revenue and provided invaluable validation of the technology.

2014

Manufacturing site acquired

Purchase of a controlling interest in Finetech Medical Limited, the only UK based company with a clean room approved under the Active Implantable Medical Devices Directive (AIMDD).

2013

Innovate UK grant awarded

Bioinduction receive a Technology Strategy Board (Innovate UK) award for our Picostim product for late‐stage Parkinson’s disease.

2009

Started Picostim development

 

Based on Acticare development, Bioinduction commenced development of an innovative deep brain stimulation device, Picostim, that is skull-mounted to increase neurosurgical productivity and improve safety.

2008

15000 Acticare shipped

 

Through our Bristol, UK and Brisbane, Australia based offices, we reached £3 million in revenue from Acticare sales.

2004

Market launch of Acticare

 

Bioinduction first product, the Acticare Transcutaneous Spinal Electroanalgesia (TSE) device for management of chronic pain is launched.

2002

Bioinduction Founded

Request a copy of the investor deck

Nature of enquiry:

Any information you provide whilst speaking to us will only be used in accordance with our Privacy & Legal Policy, and will not be used for marketing or passed to any third parties without your clear and prior consent.

Head Office

Bioinduction Ltd
178-180 Hotwell Road
Bristol, BS8 4RP
United Kingdom

 

+44 117 987 4100

Australian Office

Bioinduction Pty Ltd
1/96 Gardens Drive Willawong
Queensland 4110
Australia

 

+61 7 3107 1951

UK Manufacturing

Finetech Medical Ltd
13 Tewin Court
Welwyn Garden City, AL7 1AU
United Kingdom

 

+44 1707 330942